Open access peer-reviewed chapter

Changes in Vitamin B12, Iron, Thyroid Hormones, Thyroid Autoantibodies and Hematological Indices Levels in Patients Suffering from Helicobacter pylori Infection

Written By

Saleh Nazmy Mwafy, Wesam Mohammad Afana and Asma’a Ali Hejaze

Submitted: 18 August 2022 Reviewed: 13 September 2022 Published: 30 September 2022

DOI: 10.5772/intechopen.108036

Chapter metrics overview

195 Chapter Downloads

View Full Metrics

Abstract

Helicobacter pylori infection has been recognized as a public health problem worldwide with raising prevalence in developing than the developed countries. More than 50% of the world’s population infected, and 80% of infected have no symptoms. Megaloblastic anemia can occur due to impaired DNA synthesis resulting from deficiencies of vitamin B12 and folate. The development of autoantibodies to thyroid peroxidase (anti-TPO), thyroglobulin (anti-Tg), and thyroid-stimulating hormone receptor (TSH-R) is the main characteristic of autoimmune thyroid disease. H. pylori may decrease absorption of oral thyroxine by decreasing gastric acid secretion in the stomach. H. pylori has important role of in the development of autoimmune thyroid diseases, vitamin B12 deficiency and malfunctions of human. The primary goal of this chapter is to observe association between H. pylori infection in the gastric mucosa and of autoimmune thyroid diseases vitamin B12 deficiency because eradication of H. pylori can prevent the development of complications.

Keywords

  • vitamin B12
  • iron
  • thyroid hormones
  • thyroid autoantibodies
  • Helicobacter pylori

1. Introduction

Helicobacter pylori (H. pylori) is a spiral, flagellated, gram-negative bacteria, adapted to survive in the gastric lumen [1]. H. pylori is a bacterium that causes widespread infection, affecting over 50% of the world’s population, but 80% of infected people are asymptomatic and more common in developing countries [2].

Megaloblastic anemia can result from impaired DNA synthesis resulting from vitamin B12 (cobalamin) and folic acid deficiency. Microorganisms synthesize vitamin B12, that is primarily found in low concentration levels in meals with an animal source, humans cannot synthesize vitamin B12. Early detection of vitamin B12 deficiency and rapid treatment of is important, since it is a reversible cause of demyelinated nervous system and bone marrow failure [3]. infection with H. pylori causes gastritis and it is associated with the progress of micronutrient deficiencies, peptic ulcer, gastric carcinoma [4].

Thyroid gland is one of the crucial organs in the human body that produces basic hormones: triiodothyronine (T3) and tetra-iodothyroxine (T4) which have an essential part in control of metabolic functions, development and growth. Thyroid dysfunction affecting various vital activities; those subsequent from hypo or hyper thyroid gland action leading to increase or decrease thyroid hormones T3 and T4 [5].

Hashimoto’s thyroiditis (HT) is the most widely autoimmune thyroid disorders as one of most complications of thyroid dysfunctions. Autoimmune diseases occur when the immune system begins to attack its own self-antigens, so, that the characteristic feature of autoimmune thyroid disease is the presence of autoantibodies against thyroid antigens. Such diseases are triggered by factors including infectious agents, just like as infection with H. pylori [6, 7]. Luther et al. (2010) found that a high prevalence of people who have been diagnosed as thyroid patients were also infected with H. pylori which means that these bacteria play a critical part in the pathogenesis of such illnesses. H. pylori is one of the most well-known bacterial pathogens that infect human around the worldwide, which acquired in the early childhood and is carried throughout a lifetime if not treated with antimicrobial agents [8].

The present work sought to investigates the changes in vitamin B12, iron, thyroid hormones, thyroid autoantibodies and hematological indices levels in patients suffering from H. pylori infection.

Advertisement

2. H. pylori

2.1 General characteristics

H. pylori is considered to be as one of the furthermost common pathogenic bacteria that colonizes human stomach, varying from 70% in developing countries and less than 40% in the developed countries [9]. H. pylori is the main causative agent of gastritis and responsible for development of adenocarcinoma by stimulating cell proliferation and induces apoptosis [10]. H. pylori is a Gram- negative spiral bacteria measuring 2–4 μm in length, 0.5–1 μm in width and has 2–6 sheathed flagella 3 μm in length (Guo et al., 2011). H. pylori growth at optimal rang of: temperature 34-40C°, pH 5.5–8.0 but can survive at pH 4 and the key feature of H. pylori its microaeropholicity. Growth at optimal level of: 2–5% oxygen, 5–10% carbon dioxide and 85% nitrogen [11].

H. pylori is microaerophilic bacterium, requires lower oxygen concentrations than other bacteria to exist. It has a hydrogenase that may be utilized to generate energy by oxidizing the molecular hydrogen (H2) produced by intestinal bacteria, and it can generates urease, catalase, and oxidase [12]. These bacteria survive in the stomach for a long time without any indications in most of the infected people. In order to inhabit the stomach, H. pylori must survive in acidic pH, its persistence be influenced by the production of urease enzyme, in addition to this enzyme these pathogenic bacteria produce other enzymes which damage of host epithelial cells such as catalase, protease and phospholipase. H. pylori are vital for colonizing the stomach and make it possible for it to pass readily through the mucous layer [13].

2.2 H. pylori classification

H. pylori genus is a Helicobacteraceae family member and Campylobacterales order of proteobacteria. The digestive tracts of both humans and animals naturally contain the genus Helicobacter, which has more than 20 identified species and several more that are waiting proper classification [14].

2.3 Prevalence of H. pylori infection

H. pylori infection prevalence rates vary by age, place of origin, and socioeconomic position. Worldwide, H. pylori infection affects 50% of the population [15]. According to reports, up to 80% of people in undeveloped countries are infected with H. pylori. In Texas, the incidence of H. pylori among youngsters is 12.2%, whereas in India, it is 55.9% among people aged 11–16. [15, 16], and in northern Jordan is 82% [17] and in Gaza strip is (72.2%) [18].

2.4 Mode of transmission

2.4.1 Person-person route

Humans have been identified as a major H. pylori reservoir [19]. Person to-person contact is believed to be the primary route of transmission in developed and developing countries. Close personal relationships, especially those inside the family, between parents and children, siblings and siblings, and spouses and spouses, has been consistently verified as a major factor of transmission [20].

2.4.2 Oral-oral route

Using a polymerase chain reaction, H. pylori DNA has been found in the saliva of people who tested positive [21]. Additionally, H. pylori bacteria have been effectively found in infected dental plaque. However, isolation has not always been effective, possibly due to H. pylori’s transitory existence in the buccal cavity or low detection capabilities brought on by the co-existence of several other microorganisms.

2.4.3 Fecal-oral route

Fecal-oral is the main route of H. pylori transmission, H. pylori has been identified in human feces by culture and by PCR of its DNA. [22] Nevertheless, this has not been replicated by other researchers [23]. These findings provided evidence of the potential contribution of H. pylori fecal shedding into the environment.

2.4.4 Iatrogenic transmission

Endoscopes frequently utilized for upper gastrointestinal procedures, because they aren’t properly disinfected in between procedures, could be the cause of an iatrogenic infection [24].

2.4.5 Mechanisms of infection

Most H. pylori are located in the gastric mucosa of the stomach; however, a few are also observed adherent to the gastric mucosal epithelium. The bacteria are well suited to survive in the harsh conditions of the stomach, where very few others organisms can. Despite the fact that H. pylori is thought of as an extracellular bacteria, there is evidence that the bacteria have a method of intracellular invasion [25]. The human stomach is colonized by H. pylori, and about 50% of the worldwide people is colonized by it. Its gastric mucosa infection has been related to a variety of upper gastrointestinal tract illnesses, including chronic gastritis, peptic ulcer, stomach cancer and mucosa-associated lymphoid tissue lymphoma [26]. H. pylori typically results in an asymptomatic stomach infection, and documented side effects of this infection include chronic gastritis, peptic ulcer disease, and atrophic gastritis. Most infected individuals remain asymptomatic despite the fact that the infection almost always results in stomach inflammation, whereas a small percentage of people develop atrophic gastritis [27]. During its progression, the disease can have several manifestations including acute gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia, growth failure, malnutrition and finally cancer [28]. H pylori is the major cause of histologic gastritis and also plays an important role in the development of peptic ulcers, gastric carcinoma, and primary gastric B-cell lymphoma [29].

The etiology of atrophic gastritis and gastric cancer has been rewritten since the detection of H. pylori during the 1980s. H. pylori infection, which typically develops in early childhood and lasts a lifetime if untreated, is now recognized as the primary cause of atrophic gastritis [27]. One severe consequence of atrophic gastritis is the malabsorption of cobalamin (vitamin B12), which is frequent in the elderly due to hypo- or achlorhydria with subsequent bacterial overgrowth, and reduced production and secretion of intrinsic factor. Carmel et al., hypothesized that H. pylori infection may be crucial in the decline in acid production, the reduction in intrinsic factor secretion, and the subsequent emergence of vitamin B12 insufficiency [30]. H. pylori inhabiting the whole gastric epithelial and has a significant urease activity that results in the creation of ammonia to protect itself against the acidity of the stomach. It also produces other enzymes, including glycosulfatase and phospholipase A2 and C, which are associated with the development of stomach mucosal injury [31]. H. pylori induces an inflammatory response through the gastric epithelium, with production of pro-inflammatory cytokines, such as interleukin 1β and interleukin 8. Some H. pylori genotypes, especially those vacuolating toxin A (Vac-A) and cytotoxin-associated gene A (Cag-A) positive, are associated with greater pathogenicity and more severe sickness. Cag-A positive strains cause the stomach mucosa to react more violently to inflammation and produce more pro-inflammatory cytokines. Even while it only phenotypically manifests in 60% of H. pylori strains, the VacA gene, which causes the vacuolization and death of gastric epithelial cells, is genetically expressed in all of them [32]. Gastritis, including atrophic and non-atrophic gastritis, and peptic ulcers, are etiologically linked to H. pylori (especially duodenal ulcer). The primary gastric B-cell lymphoma (also known as mucosa-associated-lymphatic-tissue or MALT-lymphoma) and stomach adenocarcinoma have a strong correlation with H. pylori. H. pylori has been therefore classified by IARC/WHO as “group 1 carcinogen” [33].

2.5 Diagnosis of H. pylori infection

Infections are typically diagnosed by looking for dyspeptic symptoms and performing tests that may reveal H. pylori infection [34]. The diagnostic tools for H. pylori are serology, rapid urease test (RUT), urea breath test (UBT), endoscopy and biopsy/histopathology, PCR, for DNA of H. pylori and H. pylori stool antigen (HpSA). The simplest test of H. pylori is serologic, including the assessment of specific IgG level in serum [27, 35].

Advertisement

3. Anemia

3.1 Definition of anemia

Anemia is the most common blood disorder is characterized by a decrease in the number of red blood cells or a less-than-normal quantity of hemoglobin in the blood. The most widely used standards of anemia are those set by the World Health Organization, which identify hemoglobin levels of less below 12 g/dL for women and bellow 13 g/dL for males [36]. Globally, the most prevalent type of anemia was iron deficiency. It is a major public health issue that affects both advanced and developing societies, having a significant negative impact on people’s health as well as social and economic development.

3.2 Common causes of anemia

Anemia from active bleeding; Heavy menstrual bleeding or, wounds and gastrointestinal ulcers or cancers [37, 38]. Iron deficiency anemia; Inadequate food intake, poor health and improper care [39]. Anemia of chronic disease; Long-term medical condition such as a chronic infection or a cancer [40]. Anemia related to kidney disease; Diminish production of renal erythropoietin which in turn diminishes the production of RBC [41]. Anemia related to pregnancy; Water weight gain during pregnancy dilutes the blood, which may be reflected as anemia [42]. Anemia related to poor nutrition; Deficiency of vitamins and minerals required to make RBC [42]. Pernicious anemia; A problem in the stomach or the intestines leading to poor absorption of vitamin B12 [43]. Sickle cell anemia; Is due to a point mutation in the β globin gene, resulting in the creation of abnormal hemoglobin molecules with a hydrophobic motif that is exposed in its deoxygenated state [44]. Hemolytic anemia; hemolysis-related anemia, which is caused by the abnormal breakdown of RBC, blood vessels, and extravascular locations throughout the body [45]. Thalassemia; This is another group of hereditary anemia of hemoglobin related causes. It varies in severity from mild thalassemia minor to severe thalassemia major [46]. A plastic anemia; Occasionally some viral infections may severely affect the bone marrow and significantly diminish production of all blood cells chemotherapy (cancer medications) and some other medications may pose the same problems and radiation [47].

3.3 Iron deficiency anemia

3.3.1 Definition

Iron deficiency anemia (IDA) is A decrease in overall hemoglobin concentration caused on by a deficiency of iron required for maintaining normal physiologic processes. Iron deficiency anemia results from inadequate iron absorption to a accommodate an increase in requirements attributable to growth or arising from a prolonged negative iron balance, one of these conditions causes a reduction in iron storage as indicated by blood ferritin levels or bone marrow iron content [48].

3.3.2 Causes

Iron-deficiency anemia may develop from a variety of conditions, including stomach ulcers, ulcerative colitis, piles, and colon cancer, which can all induce gut bleeding and result in anemia. Anemia can be brought on by bleeding brought on by kidney or bladder illness. Anemia caused by iron deficiency can be brought on by a number of illnesses, including cancer and rheumatoid arthritis. Iron deficiency anemia is correlated with long-term aspirin use [49].

3.3.3 Diagnosis of iron deficiency anemia

Iron deficiency anemia were diagnosed by the first result on a regular complete blood count is typically low hemoglobin in the context of a lowered MCV, and the ferritin level was below 1010 ng/dl [50].

3.3.4 Pathophysiology of iron deficiency by H. pylori

Common symptoms of IDA include: breathlessness, tiredness, dizziness, tachycardia, headache and paleness [51]. The pathophysiologic mechanisms by which H. pylori is associated with the development of ID and ID anemia are not fully understood. It is still not known why some patients manifest this association and why in other patients it is not present, or there are other associations; or why some of the infections are asymptomatic [15]. Over the past decade, it has been linked H. pylori and ID development with a recently discovered hormone called hepcidin [52]. This hormone is produced in the liver and regulates iron metabolism in enterocytes and releases stored iron from macrophages of the reticuloendothelial system [53]. Hepcidin increases following H. pylori infection and acts as an acute phase reactant in reaction to the inflammation created in the gastric mucosa, culminating in a condition characterized as chronic illness or inflammatory anemia [54]. According to preliminary research, serum levels of hepcidin were raised in H. pylori-infected patients but returned to normal after the infection was eradicated, allowing the iron to be absorbed by enterocytes and freed from reticuloendothelial system macrophages, where it had been trapped [55]. Other possible causes of iron imbalance in patients infected with H. pylori are chronic gastritis, which occurs in all individuals infected with H. pylori [15]. This can cause bleeding when it becomes erosive gastritis, especially in patients with active bleeding peptic ulcers [56] and in patients who chronically ingest non-steroidal anti-inflammatory drug including aspirin [43].

3.4 Vitamin B12

3.4.1 Definition and structure

Vitamin B12 or cyanocobalamin is relatively large and complex water-soluble vitamin. The molecular weight of vitamin B12 is equal to 1355.4 [57]. All cobalamins that may be physiologically active are represented by vitamin B12. The name “cobalamin” is used to describe a class of cobalt-containing substances known as corrinoids, each of which has a lower axial ligand that contains a cobalt-coordinated nucleotide (5,6-dimethylbenzimidazole as a base. Cyanocobalamin, which is used in most supplements, is readily converted to the coenzyme forms of cobalamin (methylcobalamin and 5- deoxyadenosylcobalamin) in the human body [58]. The partial structures of vitamin B12 compounds show only those portions of the molecule that differ from vitamin B12 1: 5-deoxyadenosylcobalamin; 2,'methylcobalamin; 3, hydroxocobalamin; 4, sulfitocobalamin; 5, cyanocobalamin or vitamin B12 [57].

3.4.2 Sources of vitamin B12

Vitamin B12 is synthesized only in certain bacteria [59]. In the natural food chain system, more predatory organisms have larger concentrations of vitamin B12 that bacteria produce. The main dietary sources of vitamin B12 are thought to be animal foods (meat, milk, eggs, fish, and shellfish) rather than plant foods [58]. Some plant foods, such as edible algae or blue-green algae (cyanobacteria), however, contain large amounts of vitamin B12. Vitamin B12 compounds in algae appear to be inactive in mammals [60]. Foods contain various vitamin B12 compounds with different upper ligands; methylcobalamin and 5-deoxyadenosylcobalamin function, respectively, as coenzymes of methionine synthase (EC 2.1.1.13), which is involved in methionine biosynthesis and of methylmolonyl- CoA mutase (EC 5.4.99.2), which is involved in amino acid and odd-chain fatty acid metabolism in mammalian cells [61]. Humans have a complex process for gastrointestinal absorption of dietary vitamin B12 [62]. The recommended dietary allowance of vitamin B12 for adults is set at 2.4 μg/day in the United States and Japan; however, daily body loss of the vitamin is estimated to be between 2 and 5 μg/day [63]. According to a study by Bor et al., in 2006, a daily consumption of 6 μg of vitamin B12 is sufficient to maintain a stable level of serum vitamin B12 and vitamin B12-related metabolic indicators [64].

3.4.3 Vitamin B12 functions

Cobalamin, or vitamin B12, comes in a variety of forms, such as cyano-, methyl-, deoxyadenosyl-, and hydroxy-cobalamin. Food contains small amounts of the cyano form, which would be utilized in supplements. The other forms of cobalamin can be changed into the methyl- or 5-deoxyadenosyl forms that seem to be necessary as cofactors for L-methyl-malonyl-CoA mutase and methionine synthase. For the formation of purines and pyrimidines, methionine synthase is necessary. The reaction, in which the methyl group of methyltetrahydrofolate is transferred to homocysteine to generate methionine and tetrahydrofolate, requires folate as a co-factor and also depends on methylcobalamin. Megaloblastic anemia develops as a result of a vitamin B12 shortage and the disruption of the process that causes RBCs to mature. Megaloblastic anemia is also brought on by a folate deficit, which is unrelated to vitamin B12 [65]. Methylmalonyl CoA mutase changes methylmalonyl CoA into succinyl CoA, and it needs the cofactor 5-deoxyadenosylcobalamin to do so. The neurological consequences of vitamin B12 deficiency are assumed to be caused by a flaw in this process and the accompanying buildup of methylmalonyl CoA [65].

3.4.4 Deficiency of vitamin B12

Vitamin B12 deficiency is usually caused by the malabsorption of vitamin B12 although dietary inadequacy is common in the elderly, vegans or ovo-lacto vegetarians with poor diets. Other contributing factors include insufficient intrinsic factor synthesis, atrophic gastritis, disease-related disruption of vitamin B12 absorption in the ileum, bacterial overgrowth, resection, drug-nutrient interactions, and other less prevalent genetic abnormalities [66]. Pernicious anemia is the end stage of an auto-immune gastritis and results in the loss of synthesis of IF. It is this loss of IF that causes vitamin B12 deficiency and if untreated, megaloblastic anemia and neurological complications develop [66].

3.4.5 Mechanism of vitamin B12 deficiency

A mechanism that has been proposed to explain this association is that the action of H. pylori decreases gastric acid secretions which leads to hypochlorhydria [67]. On the one hand, protein-bound vitamin B12 must be released by the action of gastric acid in the stomach, yet hypochlorhydria itself increases the bacteria of the stomach and intestines. These bacteria may in turn make use of the vitamin B12 themselves [68]. This mechanism is supported decreased vitamin B12 levels secondary to chronic use of PPIs [69]. In addition, it has been proposed that vitamin B12 deficiency is secondary to decreased production of intrinsic factor due to atrophic gastritis (pernicious anemia) which results from chronic H. pylori infections [70]. However, one study has concluded that the association between H. pylori and vitamin B12 deficiency is independent of atrophic gastritis [71].

3.5 Thyroid hormones and autoantibodies

3.5.1 Thyroid hormones

The thyroid gland, which is shaped like a butterfly and is located at the base of the neck right behind the larynx, generates the essential hormones T4 and T3 [72]. Thyroid hormones are essential for numerous functions including: brain development, growth, fuel metabolism, reproduction, regulate body temperature and blood pressure [73]. TSH, which is made by the pituitary gland and regulates the production of T3 and T4, was responsible for controlling T3 and T4 levels. TSH production controlled by thyroid releasing hormone (TRH) produced by the hypothalamus [74]. This means that thyroid gland regulates its hormonal secretion with the aid of hypothalamus and the pituitary gland in a way that TRH is triggered pituitary to secrete TSH which in turn tells thyroid gland to capture iodine from the blood to synthesized and produced T4 and T3. Hypothalamus and pituitary gland decrease TRH and TSH when T4 is reach to a satisfactory level in circulation [75].

3.5.2 Thyroid autoantibodies

Auto-antibodies cause cellular damage and modify thyroid gland function. Sensitized T-lymphocytes and/or autoantibodies that attach to thyroid cell membranes result in cell lysis and inflammatory responses, causing cellular damage. Alterations in thyroid gland function result from the action of stimulating or blocking auto-antibodies on cell membrane receptors. TPO, Tg, and the TSH receptor are the three main thyroid auto-antigens involved in autoimmune thyroid disease (ATD). [75]. Thyroid peroxidase is the key enzyme catalyzing both the iodination and coupling reaction for the synthesis of thyroid hormone. It is membrane-bound and found in the cytoplasm of thyrocyte. It was earlier known as thyroid microsomal antigen. Anti-TPO autoantibodies are found in patients with autoimmune hypothyroidism and Graves’ disease (GD). Together with Tg antibodies, these are the predominant antibodies in Hashimoto’s thyroiditis. Anti-TPO antibodies are mainly of the IgG class with IgG1and IgG4 subclasses in excess [76].

Thyroglobulin made out of two identical subunits. It is discharged by the thyroid follicular cells into the follicular lumen and stored as the colloid. Each Tg molecule has around 100 tyrosine residues. These deposits were coupled to form the thyroid hormones T3 and T4. The sequence of human Tg has been determined [77]. Thyroglobulin autoantibodies are found in patients with lymphocytic thyroiditis and Graves’ disease patients. They are polyclonal and mainly of IgG class with all four subclasses represented. TSH controls the cell surface expression of TPO and Tg altering the mRNA transcription of these two proteins. Both blocking and stimulating Autoantibodies are found in the sera of GD patients replicate these effects [78].

Our previous experimental results [79] indicated statistically significant positive correlation between TSH levels and anti TPO and anti Tg at baseline. Also, there were statistically significant negative correlations between fT3, fT4 levels and anti-TPO and anti-Tg. This result agrees with a previous study in which statistically significant positive correlations between TSH levels and anti TPO and anti-Tg were reported. Also these findings are in agreement with that obtained by [80]. Lin et al. (2014) who found elevated levels of both anti-Tg and anti-TPO in patients with radiation-induced hypothyroidism, in addition to positive correlation between TSH and anti-Tg and a negative correlation between fT4 and anti-TPO [80].

Hou et al. (2017) who observed reduction of thyroid autoantibodies in patients with GD and HT after pharmaceutical eradication of H. pylori infection [81]. H. pylori plays role in ATD pathogenesis. Genetic factors include thyroid specific genes and immune regulatory genes while none genetic factors include: smoking, stress, iodine intake, medication, pregnancy and bacterial and virus infection that have been implicated with etiology of ATD [82]. Strong correlation between IgG anti–H. pylori antibodies and thyroid auto-antibodies as well as the observation that eradication of H. pylori infection is followed by gradual decrease in the levels of thyroid auto- antibodies, supposed that H. pylori antigens might be involved in the development of autoimmuno atrophic thyroiditis or that autoimmuno function in this disease may increase the likelihood of H. pylori infection [83]. El-Eshmawy et al., (2011) who found that a correlation between H. pylori infection and the presence of autoantibodies against thyroid antigens, and highly significant prevalence of H. pylori infection in the ATD patients when compared with healthy individuals [84].

Advertisement

4. Conclusions

H. pylori appears to play a role in the onset of IDA and vitamin B12. H. pylori patients had significant decreases in vitamin B12, serum iron and hemoglobin levels. An insufficient response to the medication may be caused by H. pylori gastritis. A raise in H. pylori IgG, anti-TPO, anti-TG, and TSH levels and a decrease in fT4, fT3, and other hematological markers appear to before H. pylori treatment in hypothyroidism Palestinian females. Patients receiving triple therapy for H. pylori infection OAC may help patients feel better overall by restoring their vitamin B12, serum iron, and hemoglobin levels. In people with gastritis, vitamin B12 levels are highly associated with Hb and RBCs. As a result, it could be thought of as a helpful indicator for patients with anemia with gastritis. H. pylori is responsible for hypothyroid patients getting large doses of L-T4 poor response. However, these parameters were nearly improved by 14-day conventional triple treatment with omeprazole, amoxicillin, and clarithromycin. Routine testing of vitamin B12, iron, ferritin and total iron binding capacity level and immunological thyroid alterations were recommended for H. pylori patients and gastroscopy confirmation of H. pylori infection.

Advertisement

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. Calam J. Discovery and bacteriology. In: Clinicians’ Guide to Helicobacter pylori. New York, NY: Springer; 1996. pp. 1-21
  2. 2. Devrajani BR et al. Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study. International Journal of Diabetes in Developing Countries. 2010;30(1):22
  3. 3. Stabler SP. Vitamin B12 deficiency. New England Journal of Medicine. 2013;368(2):149-160
  4. 4. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes and Infection. 2003;5(8):693-703
  5. 5. Thiruvengadam S, Luthra P. Thyroid disorders in elderly: A comprehensive review. Disease-a-Month. 2021;67(11):101223
  6. 6. Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders—An update. Indian Journal of Clinical Biochemistry. 2005;20(1):9-17
  7. 7. Lazúrová I, Benhatchi K. Autoimmune thyroid diseases and nonorgan-specific autoimmunity. Polskie Archiwum Medycyny Wewnetrznej. 2012;122:55-59
  8. 8. Luther J et al. Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature. Inflammatory Bowel Diseases. 2010;16(6):1077-1084
  9. 9. Minov J et al. The impact of Helicobacter pylori infection on lung function and severity of bronchial hyperresponsiveness in subjects with allergic asthma. American Journal of Immunology. 2011;7(4):62-67
  10. 10. Kim JM et al. Stimulation of dendritic cells with Helicobacter pylori vacuolating cytotoxin negatively regulates their maturation via the restoration of E2F1. Clinical & Experimental Immunology. 2011;166(1):34-45
  11. 11. Guo C et al. Genotyping analysis of Helicobacter pylori using multiple-locus variable-number tandem-repeats analysis in five regions of China and Japan. BMC Microbiology. 2011;11(1):1-7
  12. 12. Baldwin DN et al. Identification of Helicobacter pylori genes that contribute to stomach colonization. Infection and Immunity. 2007;75(2):1005-1016
  13. 13. Ahmed S, Belayneh YM. Helicobacter pylori and duodenal ulcer: Systematic review of controversies in causation. Clinical and Experimental Gastroenterology. 2019;12:441
  14. 14. Fox J. The non-H pylori helicobacters: Their expanding role in gastrointestinal and systemic diseases. Gut. 2002;50(2):273-283
  15. 15. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Digestive and Liver Disease. 2008;40(7):490-496
  16. 16. Mishra S et al. Prevalence of Helicobacter pylori in asymptomatic subjects—A nested PCR based study. Infection, Genetics and Evolution. 2008;8(6):815-819
  17. 17. Bani-Hani KE, Hammouri SM. Prevalence of Helicobacter pylori in Northern Jordan. Endoscopy based study. Saudi Medical Journal. 2001;22(10):843-847
  18. 18. Mwafy SN, Afana WM. Hematological parameters, serum iron and vitamin B 12 levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: A case–control study. Hematology, Transfusion and Cell Therapy. 2018;40:160-165
  19. 19. Stefano K et al. Helicobacter pylori, transmission routes and recurrence of infection: State of the art. Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl. 8):72
  20. 20. Khalifa MM, Sharaf RR, Aziz RK. Helicobacter pylori: A poor man's gut pathogen? Gut Pathogens. 2010;2(1):1-12
  21. 21. Leonardi M et al. Assessment of real-time PCR for Helicobacter pylori DNA detection in stool with co-infection of intestinal parasites: A comparative study of DNA extraction methods. BMC Microbiology. 2020;20(1):1-8
  22. 22. Momtaz H et al. Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World Journal of Gastroenterology: WJG. 2012;18(17):2105
  23. 23. van Zwet AA et al. Use of PCR with feces for detection of Helicobacter pylori infections in patients. Journal of Clinical Microbiology. 1994;32(5):1346-1348
  24. 24. Brown LM. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiologic Reviews. 2000;22(2):283-297
  25. 25. Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews. 2006;19(3):449-490
  26. 26. Dunne C, Dolan B, Clyne M. Factors that mediate colonization of the human stomach by Helicobacter pylori. World Journal of Gastroenterology: WJG. 2014;20(19):5610
  27. 27. Suerbaum S, Michetti P. Helicobacter pylori infection. New England Journal of Medicine. 2002;347(15):1175-1186
  28. 28. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: A vicious cycle? Pediatrics. 2007;119(3):e754-e759
  29. 29. DIXON MF. Helicobacter pylori and peptic ulceration: Histopathological aspects. Journal of Gastroenterology and Hepatology. 1991;6(2):125-130
  30. 30. Carmel R. Cobalamin, the stomach, and aging. The American Journal of Clinical Nutrition. 1997;66(4):750-759
  31. 31. Dzierzanowska-Fangrat K, Dzierzanowska D. Helicobacter pylori: Microbiology and interactions with gastrointestinal microflora. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society. 2006;57:5-14
  32. 32. Yamaoka Y. Mechanisms of disease: Helicobacter pylori virulence factors. Nature Reviews Gastroenterology & Hepatology. 2010;7(11):629-641
  33. 33. Pandey R et al. Helicobacter pylori and gastric cancer. Asian Pacific Journal of Cancer Prevention. 2010;11(3):583-588
  34. 34. Stenström B, Mendis A, Marshall B. Helicobacter pylori: The latest in diagnosis and treatment. Australian Journal of General Practice. 2008;37(8):608
  35. 35. Tiwari SK et al. Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: A non-invasive approach. Singapore Medical Journal. 2005;46(5):224-228
  36. 36. Khusun H et al. World Health Organization hemoglobin cut-off points for the detection of anemia are valid for an Indonesian population. The Journal of Nutrition. 1999;129(9):1669-1674
  37. 37. Dicato M, Plawny L, Diederich M. Anemia in cancer. Annals of Oncology. 2010;21:vii167-vii172
  38. 38. Villanueva C et al. Transfusion strategies for acute upper gastrointestinal bleeding. New England Journal of Medicine. 2013;368(1):11-21
  39. 39. Vieth JT, Lane DR. Anemia. Emergency Medicine Clinics. 2014;32(3):613-628
  40. 40. Guidi GC, Santonastaso CL. Advancements in anemias related to chronic conditions. Clinical Chemistry and Laboratory Medicine. 2010;48(9):1217-1226
  41. 41. O'Mara NB. Anemia in patients with chronic kidney disease. Diabetes Spectrum. 2008;21(1):12-20
  42. 42. Huret J-L, Dessen P, Bernheim A. Atlas of genetics and cytogenetics in oncology and haematology, year 2003. Nucleic Acids Research. 2003;31(1):272-274
  43. 43. Song HJ et al. Cost effectiveness associated with Helicobacter pylori screening and eradication in patients taking nonsteroidal anti-inflammatory drugs and/or aspirin. Gut and Liver. 2013;7(2):182
  44. 44. Malowany JI, Butany J. Pathology of sickle cell disease. Seminars in Diagnostic Pathology. 2012;29:49-55
  45. 45. Means RT. Iron deficiency and iron deficiency anemia: Implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020;12(2):447
  46. 46. Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia. The Lancet. 2012;379(9813):373-383
  47. 47. Gupta V et al. Cytogenetic profile of aplastic anaemia in Indian children. The Indian Journal of Medical Research. 2013;137(3):502
  48. 48. Baker RD, Greer FR, C.o. Nutrition, diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010;126(5):1040-1050
  49. 49. Bayraktar UD, Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World Journal of Gastroenterology: WJG. 2010;16(22):2720
  50. 50. Bermejo F, García-López S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World Journal of Gastroenterology: WJG. 2009;15(37):4638
  51. 51. Zhu A, Kaneshiro M, Kaunitz JD. Evaluation and treatment of iron deficiency anemia: A gastroenterological perspective. Digestive Diseases and Sciences. 2010;55(3):548-559
  52. 52. Park CH et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Journal of Biological Chemistry. 2001;276(11):7806-7810
  53. 53. Kroot JJ et al. Hepcidin in human iron disorders: Diagnostic implications. Clinical Chemistry. 2011;57(12):1650-1669
  54. 54. Cherian S et al. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: A cross-sectional study. PLoS One. 2008;3(12):e4030
  55. 55. Ozkasap S et al. The role of prohepcidin in anemia due to Helicobacter pylori infection. Pediatric Hematology and Oncology. 2013;30(5):425-431
  56. 56. Kang JM et al. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents. Scandinavian Journal of Gastroenterology. 2011;46(11):1295-1301
  57. 57. Watanabe F. Vitamin B12 sources and bioavailability. Experimental Biology and Medicine. 2007;232(10):1266-1274
  58. 58. Ball G. Vitamin K. In: BioaVailability and Analysis of Vitamins in Foods. Boston, MA: Springer; 1998. pp. 241-266
  59. 59. Schneider Z, Stroinski A. Biosynthesis of vitamin B12. Comprehensive B. 1987;12:93-110
  60. 60. Watanabe F et al. Characterization and bioavailability of vitamin B12-compounds from edible algae. Journal of Nutritional Science and Vitaminology. 2002;48(5):325-331
  61. 61. Fenton WA et al. Purification and properties of methylmalonyl coenzyme A mutase from human liver. Archives of Biochemistry and Biophysics. 1982;214(2):815-823
  62. 62. Russell-Jones GJ, Alpers DH. Vitamin B 12 transporters. Membrane Transporters as Drug Targets. 2002;12:493-520
  63. 63. Yates AA, Schlicker SA, Suitor CW. Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. Journal of the American Dietetic Association. 1998;98(6):699-706
  64. 64. Bor MV et al. A daily intake of approximately 6 μg vitamin B-12 appears to saturate all the vitamin B-12–related variables in Danish postmenopausal women. The American Journal of Clinical Nutrition. 2006;83(1):52-58
  65. 65. Gibson RS, Gibson RS. Principles of Nutritional Assessment. USA: Oxford University Press; 2005
  66. 66. Park S, Johnson MA. What is an adequate dose of oral vitamin B12 in older people with poor vitamin B12 status? Nutrition Reviews. 2006;64(8):373-378
  67. 67. Annibale B, Capurso G, Delle Fave G. Consequences of Helicobacter pylori infection on the absorption of micronutrients. Digestive and Liver Disease. 2002;34:S72-S77
  68. 68. Baik H, Russell R. Vitamin B12 deficiency in the elderly. Annual Review of Nutrition. 1999;19:357
  69. 69. Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Current Gastroenterology Reports. 2010;12(6):448-457
  70. 70. Lahner E, Persechino S, Annibale B. Micronutrients (other than iron) and Helicobacter pylori infection: A systematic review. Helicobacter. 2012;17(1):1-15
  71. 71. Serin E et al. Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter. 2002;7(6):337-341
  72. 72. Mohmed MSA. Evaluation of Lipids Profile among Sudanese Patients with Hypothyroidism in Khartoum State. Master thesis on SUST Repository, Sudan University of Science & Technology; 2018
  73. 73. Sherwood L. Human Physiology: From Cells to Systems. Boston, MA: Cengage Learning; 2015
  74. 74. Ferrara SJ, Bourdette D, Scanlan TS. Hypothalamic-pituitary-thyroid axis perturbations in male mice by CNS-penetrating thyromimetics. Endocrinology. 2018;159(7):2733-2740
  75. 75. Ortiga-Carvalho TM et al. Hypothalamus-pituitary-thyroid axis. Comprehensive Physiology. 2011;6(3):1387-1428
  76. 76. Kandi S, Rao P. Anti-thyroid peroxidase antibodies: Its effect on thyroid gland and breast tissue. Annals of Tropical Medicine & Public Health. 2012;5(1):1-3
  77. 77. Gardner DG. Endocrine emergencies: Myxedema coma. Greenspan's Basic Clinical Endocrinology. 2007;8:868-870
  78. 78. Iddah M, Macharia B. Autoimmune thyroid disorders. International Scholarly Research Notices. 2013;2013:1-9
  79. 79. Mwafy S, Hejaze A. Physiological Assessment of Hypothyroidism Females Infected with Helicobacter Pylori. Master thesis on AUG Repository, Al Azhar University-Gaza; 2019
  80. 80. Lin Z et al. Longitudinal study on the correlations of thyroid antibody and thyroid hormone levels after radiotherapy in patients with nasopharyngeal carcinoma with radiation-induced hypothyroidism. Head & Neck. 2014;36(2):171-175
  81. 81. Hou Y et al. Meta-analysis of the correlation between Helicobacter pylori infection and autoimmune thyroid diseases. Oncotarget. 2017;8(70):115691
  82. 82. Hamid ZA. The possible role of Helicobacter pylori infection in Hashimoto’s thyroiditis. Journal of the Faculty of Medicine Baghdad. 2017;59(1):79-82
  83. 83. Papamichael KX et al. Helicobacter pylori infection and endocrine disorders: Is there a link? World Journal of Gastroenterology: WJG. 2009;15(22):2701
  84. 84. El-Eshmawy MM et al. Helicobacter pylori infection might be responsible for the interconnection between type 1 diabetes and autoimmune thyroiditis. Diabetology & Metabolic Syndrome. 2011;3(1):1-7

Written By

Saleh Nazmy Mwafy, Wesam Mohammad Afana and Asma’a Ali Hejaze

Submitted: 18 August 2022 Reviewed: 13 September 2022 Published: 30 September 2022